DuPont Industrial Biosciences Launches New Enzyme Product for Biogas Industry

Share Article

State-of-the-Art Biotechnology Offering Will Increase Methane Yields and Improve Profitability

DuPont Oval
Customers can expect this technology to increase biogas production, improve biogas quality, shorten process time and reduce mixing costs – all supported by a global organization with continuous investment in R&D.

Today, DuPont Industrial Biosciences announced the launch of OPTIMASH® AD-100, an innovative new enzyme product that will help biomethane producers improve biogas yields and process robustness, which is expected to ultimately increase their revenue and profitability.

OPTIMASH® AD-100 represents DuPont Industrial Biosciences’ entry into the growing biogas sector, with an enzyme that has been shown to produce up to a 13 percent increase in biogas yields in anaerobic digesters. The enzyme breaks down organic matter – like food, paper, animal and farm wastes – resulting in sugars more suitable for biogas-producing microorganisms. The addition of this enzyme into the biomethane process improves the profitability for customers and operators by reducing feedstock requirements and increasing biogas production.

“DuPont is entering this market with an offering that is backed by decades of experience in the global industrial enzyme business,” said Conrad Burke, global marketing director. “Customers can expect this technology to increase biogas production, improve biogas quality, shorten process time and reduce mixing costs – all supported by a global organization with continuous investment in R&D.”

Methane biogas is primarily used to generate electricity or is compressed and inserted into the pipeline gas grid. DuPont’s Burke will be presenting at the UK AD & Biogas 2016 conference July 6 in Birmingham, England.

DuPont Industrial Biosciences works with customers across a wide range of industries to improve products and make processes more sustainable. Through a unique combination of biotechnology, chemical and material science capabilities, DuPont is focused on providing market-driven, biobased solutions to meet the needs of a growing population, while protecting the environment for future generations.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit

Forward-Looking Statements: This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry; outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of products for the agriculture industry; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and risks related to the agreement entered on December 11, 2015, with The Dow Chemical Company pursuant to which the companies have agreed to effect an all-stock merger of equals, including the completion of the proposed transaction on anticipated terms and timing, the ability to fully and timely realize the expected benefits of the proposed transaction and risks related to the intended business separations contemplated to occur after the completion of the proposed transaction. The company undertakes no duty to publicly revise or update any forward-looking statements as a result of future developments, or new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

# # #


The DuPont Oval logo, DuPont™ and all products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Wendy Rosen
Email >